Why use placebos in clinical trials? A narrative review of the methodological literature

Journal of Clinical Epidemiology

Volumn 53, Issue 2, 2000, Pages 157-161

  Vickers, Andrew J ^a   De Craen, Anton J M ^b  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Clinical trials; Double blind method; Placebos; Randomised controlled trials; Research design

Indexed keywords

PLACEBO;

CLINICAL PRACTICE; CLINICAL PROTOCOL; CLINICAL TRIAL; MEDICAL LITERATURE; METHODOLOGY; PRIORITY JOURNAL; REVIEW;

EID: 0034102525     PISSN: 08954356     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-4356(99)00139-0     Document Type: Article

References (47)

1. Ho K.H., Hashish I., Salmon P., Freeman R., Harvey W. Reduction of post-operative swelling by a placebo effect. J Psychosom Res. 32:1988;197-205.
2. Morgan J.P., Dickey J.L., Hunt H.H., Hudgins P.M. A controlled trial of spinal manipulation in the management of hypertension. J Am Osteopath Assoc. 85:1985;308-313.
3. Kokjohn K., Schmid D.M., Triano J.J., Brennan P.C. The effect of spinal manipulation on pain and prostaglandin levels in women with primary dysmenorrhea. J Manipulative Physiol Ther. 15:1992;279-285.
4. Moseley J.B., Wray N.P., Kuykendall D., Willis K., Landon G. Arthroscopic treatment of ostearthritis of the knee. a prospective, randomized, placebo-controlled study Am J Sports Med. 24:1996;28-34.
5. Campbell A. Hunting the snark. the quest for the perfect acupuncture placebo Acupunc Med. 9:1991;83-84.
6. Rothman K.J., Michels K.B. The continuing unethical use of placebo controls. N Engl J Med. 33:1994;394-397.
7. Clark P.I., Leaverton P.E. Scientific and ethical issues in the use of placebo controls in clinical trials. Annu Rev Public Health. 15:1994;19-38.
8. Ernst E., Resch K.L. Concept of true and perceived placebo effects. BMJ. 311:1995;551-553.
9. Haegerstam G., Huitfeldt B., Nilsson B.S.et al. Placebo in clinical drug trials - a multidisciplinary review. Methods Find Exp Clin Pharmacol. 4:1982;261-278.
10. Keating J.C. The placebo issue and clinical research. J Manipulative Physiol Ther. 10:1987;329-332.
11. Klerman G.L. Scientific and ethical considerations in the use of placebo controls in clinical trials in psychopharmacology. Psychopharmaco Bull. 22:1986;25-29.
12. Leber P. The placebo control in clinical trials (a view from the FDA). Psychopharmaco Bull. 22:1986;30-32.
13. Makuch RW, Johnson MF. Dilemmas in the use of active control groups in clinical research IRB Rev Hum Subjects Res 1989;11:1-5.
14. Pledger GW, Hall D. Active control trials: Do they address the efficacy issue?. Proc Am Stat Soc 1986:1-10.
15. Rickels K. Use of placebo in clinical trials. Psychopharmacol Bull. 22:1986;19-24.
16. Temple R. Government viewpoint of clinical trials. Drug Inform J. 16:1982;10-17.
17. Altman D.G. Practical statistics for medical research. 1991;Chapman and Hall, London.
18. Campbell M.J., Machin D. Medical Statistics. a Commonsense Approach:1993;John Wiley and Sons, Chichester.
19. Feinstein A.R. Clinical Epidemiology. The Architecture of Clinical Research. 1985;W.B. Saunders Company, Philadelphia, PA.
20. Fletcher R.H., Fletcher S.W., Wagner E.H. Clinical Epidemiology. The Essentials. 3rd ed:1996;Williams & Wilkins, Baltimore, MD.
21. Gordis L. Epidemiology. 1996;W.B.G. Saunders Company, Philadelphia.
22. Greenberg R.S. Medical Epidemiology. 1993;Appleton & Lange, Norwalk, CT.
23. Hennekens C.H., Buring J.E. Epidemiology in Medicine. 1987;Little, Brown and Company, Boston, MA.
24. Hulley S.B., Cummings S.R. Designing Clinical Research. 1988;Williams & Wilkins, Baltimore, MD.
25. Knapp R.G., Miller M.C. III Clinical Epidemiology and Biostatistics. 1992;Williams & Wilkins, Baltimore, MD.
26. Kramer M.S. Clinical Epidemiology and Biostatistics. 1988;Springer-Verlag, Berlin/Heidelberg.
27. Meinert C.L. Monographs in Epidemiology and Biostatistics. Clinical Trials. Design, Conduct, and Analysis (vol. 11). 1986;Oxford University Press, New York.
28. Morton R.F., Hebel J.R., McCarter R.J. A Study Guide to Epidemiology and Biostatistics. 3rd ed:1989;Aspen Publishers, Inc, Gaithersberg, MD.
29. Pocock S.J. Clinical trials. A Practical Approach:1983;John Wiley and Sons, Chichester.
30. Sackett D.L., Haynes R.B., Guyatt G.H., Tugwell P. Clinical Epidemiology. 1991;Little, Brown and Company, Boston, MA.
31. Spilker B. Guide to Clinical Studies and Developing Protocols. 1984;Raven Press, New York.
32. Weiss N.S. Monographs in Epidemiology and Biostatistics. Clinical Epidemiology. The Study of the Outcome of Illness (vol. 11):1986;Oxford University Press, New York.
33. Schulz K.F., Chalmers I., Hayes R.J., Altman D.G. Empirical evidence of bias. JAMA. 273:1995;408-412.
34. Colditz G.A., Miller J.B., Mosteller F. How study design affects outcomes in comparisons of therapy. I: Medical. Stat Med. 8(4):1989;441-454.
35. Turner J.A., Deyo R.A., Loeser J.D., Von Korff M., Fordyce W.E. The importance of placebo effects in pain treatment and research. JAMA. 271:1994;1609-1614.
36. Gracely R.H., Dubner R., Deeter W.R., Wolskee P.J. Clinicians' expectations influence placebo analgesia. Lancet. i:1985;43.
37. Pastorello E.A., Codecasa L.R., Gerosa A., Buonocore E., Sillano V., Zanussi C. The role of suggestion in asthma. I. Effects of inactive solution on bronchial reactivity under bronchoconstrictor or bronchodilator suggestion. Ann Allergy. 59:1987;336-338.
38. de Craen A.J.M., Roos P.J., de Vries A.L., Kleijnen J. Effects of colour of drugs. systematic review of perceived effect of drugs and of their effectiveness BMJ. 313:1996;1624-1626.
39. Voudouris N.J., Peck C.L., Coleman G. The role of conditioning and verbal expectancy in the placebo response. Pain. 43:1990;121-128.
40. Silagy C, Mant D, Fowler G, Lancaster T. Nicotine replacement therapy for smoking cessation. In: Lancaster T, Silagy C, Fullerton D (editors) Tobacco Addiction Model of The Cochrane Database of Systematic Reviews. Available in The Cochrane Library [database on disk and CDROM] The Cochrane Collaboration; Issue 4. Oxford: Update Software, 1998.
41. de Craen A.J.M., Vickers A.J., Tijssen J.G.P., Kleijnen J. The number-needed-to-treat and placebo-controlled trials. Lancet. 351:1998;310.
42. de Jonge J.W., Knottnerus J.A., van Zutphen W.M., de Bruijne G.A., Struijker Boudier H.A.J. Short term effect of withdrawal of diuretic drugs prescribed for ankle oedema. BMJ. 308:1994;511-513.
43. Little P., Williamson I., Warner G., Gould C., Gantley M., Kinmonth A.L. Open randomised trial of prescribing strategies in managing sore throat. BMJ. 314:1997;722-727.
44. Thomas K.B. General practice consultations. is there any point in being positive? BMJ. 294:1987;1200.
45. Gryll S.L., Katahn M. Situational factors contributing to the placebo effect. Psychopharmacology. 47:1978;253-261.
46. Skovlund E. Should we tell trial patients that they might receive placebos? Lancet. 337:1991;1041.
47. Knottnerus J.A., Dinant G.J. Medicine based evidence, a prerequisite for evidence based medicine. BMJ. 315:1997;309-310.